Unknown

Dataset Information

0

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.


ABSTRACT: Ewing sarcoma is an aggressive tumor of bone and soft tissue affecting predominantly children and young adults. Tumor-specific chromosomal translocations create EWS-FLI1 and similar aberrant ETS fusion proteins that drive sarcoma development in patients. ETS family fusion proteins and over-expressed ETS proteins are also found in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients. Transgenic expression of EWS-FLI1 in mice promotes high penetrance erythroid leukemia with dense hepatic and splenic infiltrations. We identified a small molecule, YK-4-279, that directly binds to EWS-FLI1 and inhibits its oncogenic activity in Ewing sarcoma cell lines and xenograft mouse models. Herein, we tested in vivo therapeutic efficacy and potential side effects of YK-4-279 in the transgenic mouse model with EWS-FLI1 induced leukemia. A two-week course of treatment with YK-4-279 significantly reduced white blood cell count, nucleated erythroblasts in the peripheral blood, splenomegaly, and hepatomegaly of erythroleukemic mice. YK-4-279 inhibited EWS-FLI1 target gene expression in neoplastic cells. Treated animals showed significantly better overall survival compared to control mice that rapidly succumbed to leukemia. YK-4-279 treated mice did not show overt toxicity in liver, spleen, or bone marrow. In conclusion, this in vivo study highlights the efficacy of YK-4-279 to treat EWS-FLI1 expressing neoplasms and support its therapeutic potential for patients with Ewing sarcoma and other ETS-driven malignancies.

SUBMITTER: Minas TZ 

PROVIDER: S-EPMC4741957 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Ewing sarcoma is an aggressive tumor of bone and soft tissue affecting predominantly children and young adults. Tumor-specific chromosomal translocations create EWS-FLI1 and similar aberrant ETS fusion proteins that drive sarcoma development in patients. ETS family fusion proteins and over-expressed ETS proteins are also found in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients. Transgenic expression of EWS-FLI1 in mice promotes high penetrance erythroid leukemia with  ...[more]

Similar Datasets

| S-EPMC5706912 | biostudies-literature
| S-EPMC8371434 | biostudies-literature
2020-03-21 | GSE132762 | GEO
| S-EPMC4167779 | biostudies-literature
| S-EPMC3255547 | biostudies-literature
| S-EPMC4257561 | biostudies-literature
| S-EPMC4535656 | biostudies-literature
| PRJNA548934 | ENA
| S-EPMC3084826 | biostudies-literature
| S-EPMC6125457 | biostudies-literature